Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for BOSENTAN
- A Study in Healthy Men to Test Whether Bosentan Influences the Amount of BI 425809 in the Blood
- Drug-Drug Interaction Study of Pacritinib and CYP450,Transporter Substrates, and CYP450 3A4 in Healthy Male Subjects
- Letermovir in ART-treated HIV-infected Persons
- Study to Evaluate the Effect of Bosentan on the Pharmacokinetics of Lurbinectedin in Patients With Advanced Solid Tumors
- Effect of BIA 5-1058 400 mg on the Steady State Pharmacokinetics of Bosentan
- Vascular Dysfunction in Black Individuals: Roles of Nitric Oxide and Endothelin-1
- Pirfenidone Compared to Placebo in Post-COVID19 Pulmonary Fibrosis COVID-19
- VASCULAR AND RENAL IMPACT OF ENDOTHELIN-1 RECEPTOR BLOCKADE IN PATIENTS WITH RESISTANT ARTERIAL HYPERTENSION
- Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
- Bioequivalence Study of Bosentan 125 mg Tablets Immediate Release (IR) Versus Tracleer® 125 mg Tablets IR In Healthy Subjects
- Safety of Bosentan in Type II Diabetic Patients
- Mono vs. Dual Therapy for Pediatric Pulmonary Arterial Hypertension
- Study of the Benefit of Early Treatment With an Endothelin Inhibitor (Bosentan) in Patients With Sudden Blindness Due to Giant Cell Arteritis: CECIBO
- the Effect of Tracleer on Tourniquet-associated Hypertension
- Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study
- NATIENS: Optimal Management and Mechanisms of SJS/TEN
- Macitentan in the Treatment of Organ Rejection After Lung Transplantation
- Crossover Study From Macitentan or Bosentan Over to Ambrisentan
- Bosentan Treatment of Digital Ulcers Related to Systemic Sclerosis
- Influence of Bosentan on the Pharmacokinetics of Nintedanib
- Macitentan in Pulmonary Hypertension of Sickle Cell Disease
- CSL Behring Sclero XIII
- Iloprost for Bridging to Heart Transplantation in PH
- The Clinical And Subclinical Effects on Arterial Stiffness of Bosentan in Patients With Systemic Sclerosis
- ENDOTHELION Study Group: Effect of Bosentan in NAION Patients
- Treatment of Resistant Port-wine Stains With Bosentan and Pulsed Dye Laser: a Pilot Study
- A Study to Investigate the Efficacy of PADN to Improved Functional Capacity and Hemodynamics in Patients With PAH
- Endothelin Receptor Function and Acute Stress
- Study of Bosentan in the Treatment of Stable Severe Chronic Obstructive Pulmonary Disease Patients
- Therapeutic Equivalence Between Branded and Generic WARFArin Tablets in Brazil
- Compassionate Use of Beraprost Sodium 314d Modified Release for Patients With Pulmonary Arterial Hypertension (PAH)
- Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Udenafil and Bosentan After Oral Administration
- Bosentan In Exercise Induced Pulmonary Arterial Hypertension in CongenitaL Heart diseasE
- ET-blockade and Exercise-induced Vascular Adaptations in T2DM
- ET-blockade and Exercise Induced Blood Flow in T2DM
- Safety and Efficacy Study of Bosentan for Intermittent Claudication in Peripheral Arterial Disease
- Ambrisentan for Treatment of Portopulmonary Hypertension
- Bosentan and Pulmonary Endothelial Function
- Study of the Initial Combination of Bosentan With Iloprost in the Treatment of Pulmonary Hypertension Patients
- Bosentan Therapy in Children With Functional Single Ventricle
- Examination of the Bronchoprotective Effect of Endothelin Receptor Blockade in Asthma
- Fontan Patients: Comprehensive Evaluation of Pulmonary Circulation and Ventricular Function
- A Trial of Tadalafil in Interstitial Lung Disease of Scleroderma
- Drug Therapy and Surgery in Congenital Heart Disease With Pulmonary Hypertension
- IL1-TRAP, Rilonacept, in Systemic Sclerosis
- Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis
- Comparison of Efficacy Different Treatment Regimens in Pulmonary Hypertension Secondary to Lung Disease and or Hypoxia
- Treatment of Thromboangiitis Obliterans (Buerguer's Disease) With Bosentan
- Influence of OATP1B1 and CYP2C9 Genotypes on the Pharmacokinetics of Bosentan Before and During Clarithromycin
- Bosentan in Systemic Sclerosis
- Pharmacokinetic Effects of QTI571 on Sildenafil and Bosentan in Pulmonary Arterial Hypertension Participants
- Persistent Pulmonary Hypertension of the Newborn
- Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands
- Effect of Bosentan on Endothelial Function in Patients With Type 2 Diabetes
- Characterization and Detection of Prolonged Endothelin Receptors Antagonists Administration
- FUTURE 3 Study Extension
- Efficacy and Safety of Ambrisentan in Children 8-18yrs
- Safely Change From Bosentan to Ambrisentan in Pulmonary Hypertension
- Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart Disease
- Study of Placebo or Bosentan to Treat Patients With Single Ventricle Physiology.
- Bosentan for Severe Mitral Valve Dysfunction
- Influence of CYP3A4-induction by St. John's Wort on the Steady State Pharmacokinetics of Bosentan
- A Pharmacokinetic Drug-Drug Interaction (DDI) Study Between Sitaxsentan And Sildenafil, And Between Sitaxsentan And Tadalafil After Multiple Doses
- Effect of Bosentan in Scleroderma Renal Crisis
- Effects of Two Dosing Regimens of Bosentan in Children With Pulmonary Arterial Hypertension
- Bosentan for Mild Pulmonary Vascular Disease in Asd Patients.
- Bosentan Improves Clinical Outcome of Adults With Congenital Heart Disease or Mitral Valve Lesions Who Undergo CArdiac Surgery
- Role of Endothelin-A (ETA) and Endothelin-B (ETB) Receptors in the Vasodilatory Response to Endothelin-3 (ET-3)
- Study on the Effects of Sitaxsentan on Airway Remodeling in Patients With Severe Asthma
- A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
- Effect of Bosentan in Patients With Metastatic Melanoma Treated With Dacarbazine (DTIC)
- Endothelin Blockade in Patients With Single Ventricle Physiology
- Safety and Efficacy Study of Bosentan in Progressive Pulmonary Sarcoidosis
- Early Therapy of Pulmonary Arterial Hypertension
- A Study to Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue Disease
- Insulin Resistance in Pulmonary Arterial Hypertension
- Safety and Efficacy of Bosentan in Patients With Diastolic Heart Failure and Secondary Pulmonary Hypertension
- Sitaxsentan in Proteinuric Chronic Kidney Disease
- Bosentan for Poorly Controlled Asthma
- Study Evaluating the Addition of Sildenafil to Bosentan Therapy in Pulmonary Arterial Hypertension
- Preventive Effects of Bosentan on the Systemic Cardiovascular Consequence of Sleep Apnea
- The Efficacy and Safety of Vardenafil in the Treatment of Pulmonary Arterial Hypertension
- Iloprost Power 15 in Pulmonary Arterial Hypertension
- Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
- Effects of Non-Specific Endothelin-A Receptor Blockade on Ocular Blood Flow in Patients With Glaucoma
- Effects of Bosentan on Respiratory Mechanics
- Bosentan Use in Patients With Diabetic Nephropathy
- Bosentan in Pulmonary Hypertension in Interstitial Lung Disease Treatment Study
- Open Label Extension Study in Patients With Idiopathic Pulmonary Fibrosis Who Completed Protocol AC-052-321/ BUILD 3 / NCT00391443
- Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis and Treatment With Bosentan
- Pulmonary Artery Remodelling With Bosentan
- Pharmacogenomics in Pulmonary Arterial Hypertension
- Double Blind, Randomized Trial of Bosentan for Sarcoidosis Associated Pulmonary Hypertension
- Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)
- Combination Therapy in Pulmonary Arterial Hypertension
- Effect of Bosentan on Exercise Capacity at High Altitude
- Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension
- BUILD 3: Bosentan Use in Interstitial Lung Disease
- Safety and Efficacy Study of Ambrisentan in Subjects With Pulmonary Hypertension
- Placebo Controlled Trial of Bosentan in Scleroderma Patients
- BREATHE 5-OL: Tracleer (Bosentan) in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology
- A Study of Patients Having Pulmonary Hypertension Associated With Sickle Cell Disease and Completing an ASSET Study
- Sildenafil Study to Treat Idiopathic Pulmonary Fibrosis
- Assess the Efficacy and Safety of Sildenafil When Added to Bosentan in the Treatment of Pulmonary Arterial Hypertension
- Bosentan in Digital Ulcers
- Bosentan in Children With Pulmonary Arterial Hypertension
- Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
- Open-label Study With Bosentan in Interstitial Lung Disease
- Bosentan in Children With Pulmonary Arterial Hypertension Extension Study
- Effect of Bosentan on Skin Fibrosis in Patients With Systemic Sclerosis
- Effects of Tracleer (Bosentan) on Pulmonary Arterial Hypertension Related to Eisenmenger Physiology
- Bosentan Effects in Inoperable Forms of Chronic Thromboembolic Pulmonary Hypertension
- Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients Diagnosed With Pulmonary Hypertension (PH)
- Efficacy and Safety of Bosentan in Sickle Cell Disease (SCD) Patients With Pulmonary Arterial Hypertension (PAH)
- Effects of the Combination of Bosentan and Sildenafil Versus Sildenafil Monotherapy on Pulmonary Arterial Hypertension (PAH)
- Combination Treatment With Bosentan and Sildenafil to Patients With Eisenmengers Syndrome
- The "VISION" Trial: Ventavis Inhalation With Sildenafil to Improve and Optimize Pulmonary Arterial Hypertension
- Bosentan in Treatment of Pulmonary Arterial Hypertension
- Effects of Bosentan (Tracleer) in the Course of Pulmonary Artery Hypertension Induced by Hypoxia
- Treatment of Early Systemic Sclerosis by Bosentan
- Treatment of Supine Hypertension in Autonomic Failure
- Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH)
- Combination Therapy of Bosentan and Aerosolized Iloprost in Idiopathic Pulmonary Arterial Hypertension (IPAH)
- Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II
- Trial of Iloprost Inhaled Solution as Add-On Therapy With Bosentan in Subjects With Pulmonary Arterial Hypertension (PAH)
- The Effect of Tracleer® on Male Fertility
- Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension
- Efficacy and Safety of Oral Bosentan on Healing/Prevention of Digital (Finger) Ulcers in Patients With Scleroderma
- Efficacy and Safety of Oral Bosentan in Patients With Idiopathic Pulmonary Fibrosis
- Efficacy and Safety of Oral Bosentan in Pulmonary Fibrosis Associated With Scleroderma
- Nitric Oxide and Transfusion Therapy for Sickle Cell Patients With Pulmonary Hypertension
Clinical trials list
click for details